Skip to main content

Table 1 Microorganisms recovered from BSIs in ICU in the main recent studies

From: Treatment of bloodstream infections in ICUs

Author

Marra 2011[23]

Prowle 2011[4]

Valles 2011[24]

Corona 2010[25]

Tabah 2012[12]

(countries)

(Brazil)

(Australia)

(Spain, Argentina)

(Europe, Australasia, South America, Asia)

(Europe, South America, China, Canada)

Type of BSI (number of cases)

HAB (1196)

ICU-AB (330)

CAB (343)

HCAB (131)

HAB (252)

CAB (431)

HAB (351)

ICU-AB (915)

HAB (279)

ICU-AB (877)

% MDROb

S. pneumoniae

  

21.4%

  

10.9%

1.4%

0.4%

--

--

 

S. aureus

12.8%

26.7%

10.3%a

13.8%a

9.6%a

22.3%

26.2%

23.6%

16.1%

8.4%

60%

CoNS

16.6%

24.3%

3.5%

6.2%

10.8%

16.5%

19.7%

29.6%

10%

12.7%

--

Enterococcus spp.

5.5%

17%

1.5%

4.6%

8.4%

7.2%

9.1%

11.4%

10%

12.9%

43.5%

E. coli

 

Gram negative 28.2%

20.5%

26.9

18.5%

19%

9.7%

5.6%

19%

5.1%

66.7%

Enterobacter spp.

5.8%

2.3%

6.9%

3.6%

2.6%

4.8%

6.3%

7.2%

7.6%

50%

Klebsiella spp.

11.8%

4.1%

4.6%

6.0%

4.6%

8.6%

8.5%

8.2%

15.2%

90.9%

Serratia spp.

3.2%

      

1.8%

2.6%

69%

Proteus spp.

1.8%

   

3.3%

1.4%

1.5%

1.4%

1.7%

20%

P. aeruginosa

10%

1.8%

4.6%

6.4%

6%

10.3%

9.7%

10.4%

12.5%

60%

Acinetobacter spp.

11.8%

   

0.9%

5.4%

5.7%

7.5%

15.7%

95.2%

Anaerobes

  

3.2%

1.5%

1.6%

   

3.9%

0.7%

0

Candida spp.

5.8%

15.5%

1.5%

3.8%

8.4%

4.9%

10.5%

6.5%

7.5%

8.2%

--

  1. Legend: HAB: hospital-acquired BSI, ICU-AB: ICU acquired BSI, HCAB: healthcare-associated BSI, MDRO : multi drug resistant organisms.
  2. a: MRSA represents 3% of CAB, 27.5% of HCAB and 54.1% of HAB.
  3. b: proportion of multidrug resistant organisms for both HAP and ICU-AB.